Nestlé Health Science Plans Continuum Of Care

Nestlé’s announcement on May 24 that its new health sciences subsidiary is buying Prometheus Laboratories, a gastrointestinal drug and diagnostic company, takes the food company in a new direction, but also raises questions for pharma.